115 related articles for article (PubMed ID: 28890886)
1. Development of a Novel Anti-Adhesive Vaccine Against
Faezi S; Bahrmand AR; Mahdavi M; Siadat SD; Nikokar I; Sardari S
Int J Mol Cell Med; 2017; 6(2):96-108. PubMed ID: 28890886
[TBL] [Abstract][Full Text] [Related]
2. Construction, expression, purification and characterization of secretin domain of PilQ and triple PilA-related disulfide loop peptides fusion protein from
Faezi S; Bahrmand AR; Siadat SD; Nikokar I; Sardari S; Mahdavi M
Iran J Basic Med Sci; 2017 May; 20(5):458-466. PubMed ID: 28656079
[TBL] [Abstract][Full Text] [Related]
3. Single-residue changes in the C-terminal disulfide-bonded loop of the Pseudomonas aeruginosa type IV pilin influence pilus assembly and twitching motility.
Harvey H; Habash M; Aidoo F; Burrows LL
J Bacteriol; 2009 Nov; 191(21):6513-24. PubMed ID: 19717595
[TBL] [Abstract][Full Text] [Related]
4. The Pseudomonas aeruginosa PilSR Two-Component System Regulates Both Twitching and Swimming Motilities.
Kilmury SLN; Burrows LL
mBio; 2018 Jul; 9(4):. PubMed ID: 30042200
[TBL] [Abstract][Full Text] [Related]
5. Induction of Specific Humoral Immune Response in Mice against a
Gholami M; Salimi Chirani A; Falak R; Moshiri M; Razavi S; Irajian G
Rep Biochem Mol Biol; 2018 Oct; 7(1):38-44. PubMed ID: 30324116
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice.
Gholami M; Chirani AS; Razavi S; Falak R; Irajian G
Lett Appl Microbiol; 2017 Nov; 65(5):439-445. PubMed ID: 28857243
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of novel Pseudomonas aeruginosa type IV pilins.
Nguyen Y; Jackson SG; Aidoo F; Junop M; Burrows LL
J Mol Biol; 2010 Jan; 395(3):491-503. PubMed ID: 19895819
[TBL] [Abstract][Full Text] [Related]
8. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
10. The Pseudomonas aeruginosa ribbon-helix-helix DNA-binding protein AlgZ (AmrZ) controls twitching motility and biogenesis of type IV pili.
Baynham PJ; Ramsey DM; Gvozdyev BV; Cordonnier EM; Wozniak DJ
J Bacteriol; 2006 Jan; 188(1):132-40. PubMed ID: 16352829
[TBL] [Abstract][Full Text] [Related]
11. Mucosal fluid glycoprotein DMBT1 suppresses twitching motility and virulence of the opportunistic pathogen Pseudomonas aeruginosa.
Li J; Metruccio MME; Evans DJ; Fleiszig SMJ
PLoS Pathog; 2017 May; 13(5):e1006392. PubMed ID: 28489917
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection.
Banadkoki AZ; Keshavarzmehr M; Afshar Z; Aleyasin N; Fatemi MJ; Behrouz B; Hashemi FB
Biologicals; 2016 Sep; 44(5):367-73. PubMed ID: 27427517
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the components of the general secretion pathway: role of Pseudomonas aeruginosa type IV pilin subunits in complex formation and extracellular protein secretion.
Lu HM; Motley ST; Lory S
Mol Microbiol; 1997 Jul; 25(2):247-59. PubMed ID: 9282737
[TBL] [Abstract][Full Text] [Related]
14. Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization.
Ahmadbeigi Y; Chirani AS; Soleimani N; Mahdavi M; Goudarzi M
Mol Immunol; 2020 Aug; 124():70-82. PubMed ID: 32540517
[TBL] [Abstract][Full Text] [Related]
15. A Highly Dynamic Loop of the Pseudomonas aeruginosa PA14 Type IV Pilin Is Essential for Pilus Assembly.
Nguyen Y; Boulton S; McNicholl ET; Akimoto M; Harvey H; Aidoo F; Melacini G; Burrows LL
ACS Infect Dis; 2018 Jun; 4(6):936-943. PubMed ID: 29342354
[TBL] [Abstract][Full Text] [Related]
16. A trivalent vaccine consisting of "flagellin A+B and pilin" protects against Pseudomonas aeruginosa infection in a murine burn model.
Hashemi FB; Behrouz B; Irajian G; Laghaei P; Korpi F; Fatemi MJ
Microb Pathog; 2020 Jan; 138():103697. PubMed ID: 31465785
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa Type IV pilus expression in Neisseria gonorrhoeae: effects of pilin subunit composition on function and organelle dynamics.
Winther-Larsen HC; Wolfgang MC; van Putten JP; Roos N; Aas FE; Egge-Jacobsen WM; Maier B; Koomey M
J Bacteriol; 2007 Sep; 189(18):6676-85. PubMed ID: 17573479
[TBL] [Abstract][Full Text] [Related]
18. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B
Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
[TBL] [Abstract][Full Text] [Related]
19. [Prokaryotic expression of pilA gene of type I pilus of enteropathogenic Escherichia coli isolated from ducks and the immunoprotection effect of recombinant expression protein challenged with virulent strains].
Cheng AC; Yu XN; Wang MS; Zhu DK; Li L; Sun L; Chen XY
Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):440-5. PubMed ID: 17577990
[TBL] [Abstract][Full Text] [Related]
20. Truncated type IV pilin PilA(108) activates the intramembrane protease AlgW to cleave MucA and PilA(108) itself in vitro.
Li R; Withers RT; Dai J; Ruan J; Li W; Dai Y; An W; Yu D; Wei H; Xia M; Tian C; Yu HD; Qiu D
Arch Microbiol; 2016 Nov; 198(9):885-92. PubMed ID: 27270273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
